HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

2nd Edition of International Heart Congress

June 20-22,2024 | Hybrid Event

June 20 -22, 2024 | Paris, France
Heart Congress 2024

Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up through biodesign-inspired and biotech-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety

Sergey Suchkov, Speaker at Cardiovascular Conference
The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up through biodesign-inspired and biotech-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety

Abstract:

A new systems approach to diseased states and wellness result in a new branch in the healthcare ser-vices, namely Personalized and Precision Medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the recognition of biomarkers and thus the targets to secure the grand future of drug design and drug discovery. It would be extremely useful to integrate data harvesting from different databanks for applications such as prediction and personalization of further treatment to thus provide more tailored measures for the patients resulting in improved patient outcomes, reduced adverse events, and more cost effective use of the latest health care resources including diagnostic (companion ones), preventive and therapeutic (targeted molecular and cellular) etc. A major paradigm shift has become the increasing recognition of the potential therapeutic utility of the targeted drugs for cardiovascular diseases, whilst opening up new avenues of therapeutic implications. As PPM continues to drive targeted immunotherapy development and cardiac biomarker discovery for healthcare services, cardiologists could indeed see their own PPM-based renaissance very soon. In cardiovascular disease, PPM may result in much-needed innovation in the field and has the potential to eventually change the way we treat heart diseases altogether. And PPM and PPC are thus poised to become the next great revolution in the daily practice, as well as in the maintenance of cardiovascular health and the prevention and cure of cardiovascular disease. PPM disrupts standard practice and draws from clinical testing, electronic health records, pan-omics profiling, big datasets, and novel analytical methods, to create a person-specific phenotype that can then be used to identify an optimal intervention with minimal risk. Encompassing functional cardiology, integrative medicine, and metabolic medicine/cardiology, we would suggest an up-to-date, expert approach to heart health wellness and treating the diseased heart and blood vessels. The proposal would ideally be suited for practitioners who already incorporate integrative approaches in their practice, as well as more traditional clinicians who want to learn more about PPM and PPC as a growing area. In short, PPM will transform the way the physicians practice and will shake up the entire pharmaceutical value chain.

Audience Take Away

  • The upgraded philosophy of Personalized and Precision Medicine as applicable to Cardiology
  • To define the approaches to applied in the daily practice to assess patients in an individualized style
  • For sure, for the Mode of Lecture and Lecture Training Courses
  • In a stepwise manner
  • Through the View of Biodesign-inspired and Biotech-driven Translational Research aiming at the targeted cardiology-related problem

Biography:

Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, Suchkov maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology. In 2001, Suchkov maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1989 through 1995, Dr Suchkov was being a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004 - a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, Dr Suchkov was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK.

Watsapp